Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2023-08-10

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2023-08-01

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2023-06-23

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2023-05-23

View Filing

NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form Type: NT 10-Q

Filing Date: 2023-05-15

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2023-04-07

View Filing

8-K/A [Amend] - Current report

Form Type: 8-K/A

Filing Date: 2023-04-06

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2023-02-10

View Filing

SC 13G - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G

Filing Date: 2023-02-08

View Filing

NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form Type: NT 10-K

Filing Date: 2023-01-30

View Filing